GLUE
GLUE

Monte Rosa Therapeutics Inc

NASDAQ · Biotechnology
$19.55
+0.65 (+3.44%)
Analyst Consensus
Strong Buy
15 analysts
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +96.7% upside
Low Target $28.40
Average Target $38.45
High Target $50.36
Current Price $19.55
Current
$19.55
Target
$38.45
$28.40 $38.45 avg $50.36